Upgrade to SI Premium - Free Trial

Accuride (ACW)

2.58 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- M&A (12/31/16 *Est)

Latest Headlines

Xanamem proof-of-concept trial demonstrating anti-depressant activity published in the British Journal of Psychiatry July 20, 2026 8:51 AM - Globe NewsWire Full Article List